1. Home
  2. ITCI vs INGR Comparison

ITCI vs INGR Comparison

Compare ITCI & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • INGR
  • Stock Information
  • Founded
  • ITCI 2002
  • INGR 1906
  • Country
  • ITCI United States
  • INGR United States
  • Employees
  • ITCI N/A
  • INGR N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • INGR Packaged Foods
  • Sector
  • ITCI Health Care
  • INGR Consumer Staples
  • Exchange
  • ITCI Nasdaq
  • INGR Nasdaq
  • Market Cap
  • ITCI 8.0B
  • INGR 8.7B
  • IPO Year
  • ITCI N/A
  • INGR 1997
  • Fundamental
  • Price
  • ITCI $86.40
  • INGR $133.17
  • Analyst Decision
  • ITCI Strong Buy
  • INGR Buy
  • Analyst Count
  • ITCI 12
  • INGR 6
  • Target Price
  • ITCI $97.00
  • INGR $138.83
  • AVG Volume (30 Days)
  • ITCI 459.9K
  • INGR 267.4K
  • Earning Date
  • ITCI 10-30-2024
  • INGR 11-05-2024
  • Dividend Yield
  • ITCI N/A
  • INGR 2.40%
  • EPS Growth
  • ITCI N/A
  • INGR 14.14
  • EPS
  • ITCI N/A
  • INGR 9.79
  • Revenue
  • ITCI $564,526,000.00
  • INGR $7,714,000,000.00
  • Revenue This Year
  • ITCI $46.60
  • INGR N/A
  • Revenue Next Year
  • ITCI $37.06
  • INGR $0.52
  • P/E Ratio
  • ITCI N/A
  • INGR $13.63
  • Revenue Growth
  • ITCI 54.31
  • INGR N/A
  • 52 Week Low
  • ITCI $46.10
  • INGR $91.60
  • 52 Week High
  • ITCI $84.89
  • INGR $138.37
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 73.36
  • INGR 43.25
  • Support Level
  • ITCI $75.57
  • INGR $134.61
  • Resistance Level
  • ITCI $79.46
  • INGR $136.69
  • Average True Range (ATR)
  • ITCI 2.42
  • INGR 1.77
  • MACD
  • ITCI 0.60
  • INGR -0.21
  • Stochastic Oscillator
  • ITCI 88.13
  • INGR 19.56

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.

Share on Social Networks: